PUBLISHER: BCC Research | PRODUCT CODE: 1225598
PUBLISHER: BCC Research | PRODUCT CODE: 1225598
The global market for sleep aids is estimated to increase from $89.6 billion in 2022 to reach $125.3 billion by 2027, at a compound annual growth rate (CAGR) of 6.9% from 2022 through 2027.
North American market for sleep aids is estimated to increase from $30.0 billion in 2022 to reach $42.1 billion by 2027, at a CAGR of 7.0% from 2022 through 2027.
Asia-Pacific market for sleep aids is estimated to increase from $24.5 billion in 2022 to reach $36.8 billion by 2027, at a CAGR of 8.4% from 2022 through 2027.
This report offers a detailed picture of the sleep aids market.
This report highlights the current and future market potential for sleep aids and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as key market players.
This report details market shares for sleep aids based on product, sleep disorder and geography. Based on product, the market is segmented into mattresses and pillows, sleep apnea devices, medications, sleep laboratories, and home sleep tests. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS) and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2021 through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.